Netmed Inc
OTC:NTME
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its Industry Average (12.9), the stock would be worth $-0 (1 720% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -0.8 | $0 |
0%
|
| Industry Average | 12.9 | $-0 |
-1 720%
|
| Country Average | 14.4 | $-0 |
-1 905%
|
Forward EV/EBITDA
Today’s price vs future ebitda
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| US |
N
|
Netmed Inc
OTC:NTME
|
548.5k USD | -0.8 | -2.1 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
161B USD | 14 | 25.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
160.3B USD | 46 | 60.6 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.2B USD | 20.1 | 39.2 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
105.2B USD | 12.9 | 23.1 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
88.3B USD | 19.6 | 33 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
42.9B EUR | 11 | 19.7 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46.3B USD | 23.8 | 43.7 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.4B USD | 30.8 | 43.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.6B USD | 10 | 25.2 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
32.9B USD | 11.3 | 15.6 |
Market Distribution
| Min | 0 |
| 30th Percentile | 10 |
| Median | 14.4 |
| 70th Percentile | 21.5 |
| Max | 1 767 274.1 |
Other Multiples
Netmed Inc
Glance View
NetMed, Inc. engages in the research and development of proprietary ceramic-based technology for separation of oxygen from ambient air and other gases. The company is headquartered in Dublin Ohio, Ohio and currently employs 1 full-time employees. During the fiscal year ended December 31, 2001, the Company's sole business activity, through its majority-owned subsidiary, OxyNet, Inc., involved research and development activities associated with a proprietary ceramic-based technology for separation of oxygen from ambient air and other gases. These activities were suspended effective December 31, 2001, pending efforts to locate a prospective licensee or development partner. The firm is continuing efforts, begun in 2001, to evaluate other business opportunities, which included preliminary investigation and due diligence. These efforts have not, in the judgment of the Company's management, produced an attractive merger or acquisition candidate. The firm is seeking a candidate with a proprietary product or service, which may be in the development stage, and offers an opportunity to realize these objectives.
